Moving beyond monotherapy in first line HCC: What will be the new standard for the expected clinical and patient outcomes?

Date 20 October 2018
Event ESMO 2018 Congress
Session ESMO COLLOQUIUM - Hepatocellular arcinoma treatment: Now, next and beyond
Topics Hepatobiliary Cancers
Presenter Arndt Vogel
Authors A. Vogel
  • ., Medizinische Hochschule Hannover, Hannover/DE